S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

ZoomInfo Faces Class Action Over Alleged Misleading AI Growth Claims

Investors who purchased ZoomInfo Technologies stock between November 3, 2025, and May 11, 2026, are now the target of a class action lawsuit. The filing alleges that the company misled shareholders by inflating growth projections for its AI-powered products while customers were quietly shifting toward in-house alternatives.

ZoomInfo Faces Class Action Over Alleged Misleading AI Growth Claims
Photo: Bio & News

The complaint, filed under the Securities Exchange Act of 1934, asserts that ZoomInfo’s public optimism regarding its AI suite masked a deteriorating competitive position. While the company touted robust adoption, the lawsuit claims management was aware that clients were increasingly abandoning ZoomInfo’s platform to develop proprietary AI solutions. These undisclosed operational headwinds suggest the company's financial guidance throughout the specified period was materially inaccurate.

Shareholders seeking to participate in the litigation must act before the August 24, 2026, deadline. The DJS Law Group is currently coordinating the case, inviting investors who suffered losses to explore potential lead plaintiff appointments. Participation in the recovery process does not strictly require a formal lead plaintiff designation, though legal counsel recommends that affected institutional and individual investors review their portfolio documentation to assess eligibility.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!